Literature DB >> 10757474

Linkage analysis of moyamoya disease on chromosome 6.

T K Inoue1, K Ikezaki, T Sasazuki, T Matsushima, M Fukui.   

Abstract

Genetic factors have been suggested to contribute to the etiology of moyamoya disease. The authors have previously reported an association between moyamoya disease and several alleles for human leukocyte antigens (HLA). To further specify the genetic component of moyamoya disease, a linkage study of moyamoya disease using markers on chromosome 6, where the HLA gene is located, was performed. The 15 microsatellite markers of chromosome 6 were studied in 20 affected sibling pairs. From an identical-by-descent analysis of these markers, an allele with possible linkage to moyamoya disease was identified. Sharing of the allele among affected members in 19 families was investigated, considering the haplotype. The marker, D6S441, might be linked to moyamoya disease. Considering the haplotype, the allele was shared among the affected members in 16 (82%) of the 19 families, but not in two others. In one family, sharing of the allele could not be determined because of low heterozygosity. Further studies are necessary to clarify multiple genetic factors that are definitely linked with moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757474     DOI: 10.1177/088307380001500307

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  51 in total

1.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

Review 2.  [Moyamoya disease].

Authors:  P Papanagiotou; I Q Grunwald; M Politi; C Roth; W Reith
Journal:  Radiologe       Date:  2005-05       Impact factor: 0.635

3.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

Review 4.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

5.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

Review 6.  Inherited neurovascular diseases affecting cerebral blood vessels and smooth muscle.

Authors:  Christine Sam; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-04-21       Impact factor: 3.584

7.  Moyamoya disease in pregnancy: maintenance of maternal blood pressure.

Authors:  Helen L Barrett; Karin Lust; Narelle Fagermo; Leonie K Callaway; Lee Minuzzo
Journal:  Obstet Med       Date:  2011-12-08

8.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

Review 9.  Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan.

Authors:  Sana Shoukat; Ahmed Itrat; Ather M Taqui; Moazzam Zaidi; Ayeesha K Kamal
Journal:  BMC Neurol       Date:  2009-04-15       Impact factor: 2.474

10.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.